This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Everson, M. P. Articles by Chandler, D. B. Search for Related Content PubMed PubMed Citation Articles by Everson, M. P. Articles by Chandler, D. B.

American Journal of Pathology, Vol 140, 503-512, Copyright © 1992 by American Society for Investigative Pathology

REGULAR ARTICLES

Changes in distribution, morphology, and tumor necrosis factor-alpha secretion of alveolar macrophage subpopulations during the development of bleomycin-induced pulmonary fibrosis

MP Everson and DB Chandler
Department of Pathology, University of Alabama, Birmingham.

Previous studies indicate that heterogeneous alveolar macrophages (AM) play a pivotal role in events associated with bleomycin-induced pulmonary fibrosis. A critical role has been suggested for tumor necrosis factor-alpha (TNF-alpha), a product of activated macrophages, in this fibrotic process. The present study examined whether the characteristics and function (TNF-alpha secretion) of rat AM subpopulations were altered during the development of bleomycin-induced fibrosis. After intratracheal bleomycin treatment, AM were separated into 18 density-defined subpopulations. Bleomycin treatment altered the distribution and morphology of AM subpopulations of densities 1.017 to 1.061 g/ml at all time points studied (4, 14, and 28 days). Subpopulations of densities 1.090 to 1.141 g/ml were affected only at 4 days after bleomycin treatment. Tumor necrosis factor-alpha secretion increased with time in 14- and 28-day samples of bleomycin-treated rats, particularly in subpopulations of densities 1.075 to 1.097 g/ml. These data indicate that alterations in the distribution, morphology, and function of AM subpopulations accompany the development of bleomycin-induced pulmonary fibrosis. When coupled with previous studies suggesting that TNF-alpha plays a role in the fibrotic process in this disease model, these data indicate that AM of densities 1.075 to 1.097 g/ml are responsible for the production of TNF-alpha associated with bleomycin-induced pulmonary fibrosis.

This article has been cited by other articles:

				F. Saito, S. Tasaka, K.-i. Inoue, K. Miyamoto, Y. Nakano, Y. Ogawa, W. Yamada, Y. Shiraishi, N. Hasegawa, S. Fujishima, et al. Role of Interleukin-6 in Bleomycin-Induced Lung Inflammatory Changes in Mice Am. J. Respir. Cell Mol. Biol., May 1, 2008; 38(5): 566 - 571. [Abstract] [Full Text] [PDF]

				L. A. Ortiz, K. Moroz, J.-Y. Liu, G. W. Hoyle, T. Hammond, R. F. Hamilton, A. Holian, W. Banks, A. R. Brody, and M. Friedman Alveolar macrophage apoptosis and TNF-alpha , but not p53, expression correlate with murine response to bleomycin Am J Physiol Lung Cell Mol Physiol, December 1, 1998; 275(6): L1208 - L1218. [Abstract] [Full Text] [PDF]

				B. A. Dubaybo, G. Bayasi, and G. J. Rubeiz CHANGES IN TUMOR NECROSIS FACTOR IN POSTPNEUMONECTOMY LUNG GROWTH J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 396 - 404. [Abstract] [Full Text]